Essential oil of Perilla frutescens-induced change in hippocampal expression of brain-derived neurotrophic factor in chronic unpredictable mild stress in mice

被引:49
|
作者
Yi, Li-Tao [1 ]
Li, Jing [1 ]
Geng, Di [1 ]
Liu, Bin-Bin [1 ]
Fu, Ying [2 ]
Tu, Jia-Qi [2 ]
Liu, Yuan [2 ]
Weng, Lian-Jin [1 ]
机构
[1] Huaqiao Univ, Coll Chem Engn, Dept Chem & Pharmaceut Engn, Xiamen 361021, Fujian Province, Peoples R China
[2] Huaqiao Univ, Coll Chem Engn, Dept Biotechnol & Bioengn, Xiamen 361021, Fujian Province, Peoples R China
基金
中国国家自然科学基金;
关键词
Antidepressant; Perilla frutescens; Essential oil; Brain-derived neurotrophic factor; Chronic unpredictable mild stress; MESSENGER-RNA EXPRESSION; FORCED SWIMMING TEST; ST-JOHNS-WORT; SUCROSE PREFERENCE; STRAIN DIFFERENCES; ANIMAL-MODELS; ANTIDEPRESSANT; BDNF; DEPRESSION; SCHIZOPHRENIA;
D O I
10.1016/j.jep.2013.03.015
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmnacological relevance: Perilla frutescens (Perilla leaf), a traditional Chinese medicinal herb, has been used for centuries to treat various conditions including depression. A previous study of the authors demonstrated that essential oil of Perilla frutescens (EOPF) attenuated the depressive-like behavior in mice. Aim of the study: This study was undertaken to explore the dynamic change of behaviors and brain-derived neurotrophic factor (BDNF) expression induced by chronic unpredictable mild stress (CUMS), and improved by EOPF. Materials and methods: Four separate CUMS experimental groups (1-week, 2-week, 3-week and 4-week treatment) were treated with EOPF (3 mg/kg and 6 mg/kg, p.o.) or fluoxetine (20 mg/kg, p.o.), followed by sucrose preference, locomotor activity, immobility and hippocampal BDNF measurement. Results: EOPF, as well as fluoxetine, restored the CUMS-induced decreased sucrose preference and increased immobility time, without affecting body weight gain and locomotor activity. Furthermore, CUMS (3 or 4-week) produced a reduction in both BDNF mRNA and protein expression in the hippocampus, which were ameliorated by EOPF (4-week) and fluoxetine (3 or 4-week) treatment. Conclusion: These results presented here show that BDNF is expressed depending on length of CUMS procedure and EOPF administration. And this study might contribute to the underlying reason for the slow onset of antidepressant activity in clinic. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 50 条
  • [41] The Impacts of Swimming Exercise on Hippocampal Expression of Neurotrophic Factors in Rats Exposed to Chronic Unpredictable Mild Stress
    Jiang, Pei
    Dang, Rui-Li
    Li, Huan-De
    Zhang, Li-Hong
    Zhu, Wen-Ye
    Xue, Ying
    Tang, Mi-Mi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [42] Brain-derived neurotrophic factor expression in serotonergic neurons improves stress resilience and promotes adult hippocampal neurogenesis
    Leschik, Julia
    Gentile, Antonietta
    Cicek, Cigdem
    Peron, Sophie
    Tevosian, Margaryta
    Beer, Annika
    Radyushkin, Konstantin
    Bludau, Anna
    Ebner, Karl
    Neumann, Inga
    Singewald, Nicolas
    Berninger, Benedikt
    Lessmann, Volkmar
    Lutz, Beat
    PROGRESS IN NEUROBIOLOGY, 2022, 217
  • [43] Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor
    Viviani, B
    Bartesaghi, S
    Corsini, E
    Villa, P
    Ghezzi, P
    Garau, A
    Galli, CL
    Marinovich, M
    JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) : 412 - 421
  • [44] Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains
    Dunham, J. S.
    Deakin, J. F. W.
    Miyajima, F.
    Payton, A.
    Toro, C. T.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2009, 43 (14) : 1175 - 1184
  • [45] Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons
    Lee, TH
    Kato, H
    Chen, ST
    Kogure, K
    Itoyama, Y
    NEUROREPORT, 2002, 13 (17) : 2271 - 2275
  • [46] Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
    Fukumoto, T
    Morinobu, S
    Okamoto, Y
    Kagaya, A
    Yamawaki, S
    PSYCHOPHARMACOLOGY, 2001, 158 (01) : 100 - 106
  • [47] Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
    Takuji Fukumoto
    Shigeru Morinobu
    Yasumasa Okamoto
    Ariyuki Kagaya
    Shigeto Yamawaki
    Psychopharmacology, 2001, 158 : 100 - 106
  • [48] Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis
    Coffey, Charles S.
    Mulligan, Ryan M.
    Schlosser, Rodney J.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2009, 23 (06) : 571 - 574
  • [49] Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons
    Li, YX
    Zhang, YO
    Lester, HA
    Schuman, EM
    Davidson, N
    JOURNAL OF NEUROSCIENCE, 1998, 18 (24): : 10231 - 10240
  • [50] Hippocampal Epigenetic Modification at the Brain-Derived Neurotrophic Factor Gene Induced by an Enriched Environment
    Kuzumaki, Naoko
    Ikegami, Daigo
    Tamura, Rie
    Hareyama, Nana
    Imai, Satoshi
    Narita, Michiko
    Torigoe, Kazuhiro
    Niikura, Keiichi
    Takeshima, Hideyuki
    Ando, Takayuki
    Igarashi, Katsuhide
    Kanno, Jun
    Ushijima, Toshikazu
    Suzuki, Tsutomu
    Narita, Minoru
    HIPPOCAMPUS, 2011, 21 (02) : 127 - 132